Development and Clinical Evaluation of a Biodegradable Antibacterial Scaffold for Guided Bone Regeneration in Dental Implants
Table Of Contents
Chapter ONE
INTRODUCTION
- 1.1Introduction
- 1.2Background of Study
- 1.3Problem Statement
- 1.4Objective of Study
- 1.5Limitation of Study
- 1.6Scope of Study
- 1.7Significance of Study
- 1.8Structure of the Research
- 1.9Definition of Terms
Chapter TWO
LITERATURE REVIEW
- 2.1Review of Related Theories in Guided Bone Regeneration
- 2.2Biodegradable Scaffolds: Materials and Degradation Profiles
- 2.3Antibacterial Agents in Dental Biomaterials
- 2.4Scaffold Design and Fabrication Techniques
- 2.5Surface Modification for Osteoconductivity and Antimicrobial Properties
- 2.6Clinical Outcomes of Guided Bone Regeneration in Implants
- 2.7Biomechanics of Implant-Bone Interface
- 2.8In Vitro Evaluation Methods for Dental Scaffolds
- 2.9In Vivo Evaluation Models for Bone Regeneration
- 2.10Regulatory and Ethical Considerations in Biomaterials Research
Chapter THREE
RESEARCH METHODOLOGY
- 3.1Research Design and Rationale
- 3.2Materials Selection and Preparation
- 3.3Scaffold Fabrication Methodology
- 3.4Antibacterial Agent Incorporation and Release Kinetics
- 3.5In Vitro Biocompatibility and Cytotoxicity Testing
- 3.6In Vitro Antibacterial Efficacy Testing
- 3.7Mechanical Characterization of Scaffolds
- 3.8In Vivo Animal Model for Guided Bone Regeneration
- 3.9Ethical Considerations and Approval Processes
- 3.10Data Collection and Statistical Analysis
Chapter FOUR
DATA PRESENTATION AND ANALYSIS
- 4.1Characterization of Scaffold Morphology and Composition
- 4.2Degradation Behavior in Physiologic Conditions
- 4.3Antibacterial Release Profile and Kinetics
- 4.4In Vitro Cell Proliferation and Differentiation Assays
- 4.5Osteoconductivity and Mineralization Assessments
- 4.6Biomechanical Testing of the Implant–Bone Interface
- 4.7In Vivo Regeneration Outcomes and Histological Analysis
- 4.8Comparative Analysis with Conventional GBR Materials
Chapter FIVE
SUMMARY, CONCLUSION AND RECOMMENDATIONS
- 5.1Summary of Findings
- 5.2Discussion of Results in Context of Existing Literature
- 5.3Implications for Clinical Practice
- 5.4Limitations of the Study
- 5.5Recommendations for Future Research
- 5.6Conclusions
Project Abstract
This study reports the design, synthesis, and clinical evaluation of a biodegradable antibacterial scaffold engineered for guided bone regeneration (GBR) in dental implantology. The scaffold combines a bioactive polymeric matrix with osteoconductive ceramic fillers and encapsulated antibacterial agents to address both osseous regeneration and infection control at implant sites. Biocompatible polymers, such as poly(lactic-co-glycolic acid) (PLGA) and polycaprolactone (PCL), were integrated with hydroxyapatite (HA) and beta-tricalcium phosphate (?-TCP) to provide a hierarchical porous architecture that supports vascular ingrowth and osteoblastic differentiation. The antibacterial functionality was achieved through encapsulation of silver nanoparticles and a slow-release antibiotic/antimicrobial peptide, achieving sustained local concentrations while minimizing systemic exposure. In vitro characterization demonstrated appropriate porosity (>70% interconnected porosity), pore sizes ranging from 100 to 400 ?m, and controlled degradation kinetics aligned with the typical bone healing window (6–12 weeks). Mechanical testing indicated compressive strengths compatible with cancellous bone to support early load-bearing during the regenerative phase. Antibacterial assays showed potent activity against common oral pathogens, including Staphylococcus aureus and Enterococcus faecalis, with a prolonged release profile extending beyond 4 weeks. In vitro cytocompatibility assays with human mesenchymal stem cells and osteoblasts indicated high cell viability, proliferation, and expression of osteogenic markers such as RUNX2, ALP, and OCN, under osteogenic induction. An optimized formulation demonstrated minimal cytotoxicity while preserving antimicrobial efficacy. A preclinical in vivo assessment in a rabbit calvarial critical-size defect model and a canine peri-implantitis model evaluated bone formation, implant integration, and infection control under GBR conditions. Micro-CT analyses revealed significantly enhanced bone volume fraction and trabecular thickness in scaffold-treated defects compared with controls, with histomorphometric measurements showing increased new bone formation at 8 and 12 weeks. Immunohistochemical staining confirmed elevated osteogenic activity and vascularization within the scaffold region. In a peri-implantitis scenario, the scaffold reduced bacterial load, suppressed inflammatory cytokines, and promoted favorable peri-implant bone remodeling, contributing to improved implant stability. The study also monitored degradation products and systemic safety, confirming biocompatibility and negligible systemic toxicity. A finite element analysis supported the mechanical stability of implants supported by the scaffold under masticatory loading. The translational potential of this biodegradable antibacterial GBR scaffold is underscored by its tunable degradation rate, favorable handling characteristics, and compatibility with standard implant protocols. Limitations include variability in patient-specific healing responses and the need for long-term clinical trials to assess long-term outcomes and potential resistance development. Overall, the scaffold demonstrates a promising dual-function approach—facilitating robust bone regeneration while mitigating infection risks—thereby enhancing osseointegration and implant longevity in compromised periodontal environments.
Project Overview
What This Project Is About
The project looks at a special scaffold (a temporary support structure) that helps bone grow where a dental implant will go. It is designed to slowly degrade in the body while releasing safe antibacterial agents to keep the area clean and support healing. The study checks how well this scaffold supports bone regeneration and how safe and practical it is for clinical use.
The Problem It Addresses
Dental implants require strong bone to hold them in place. In many patients, bone is weak or damaged, making implants risky. Infections after surgery can also hinder healing. The scaffold aims to provide a temporary framework that promotes bone growth while preventing infection, addressing both structural and microbial challenges.
Objectives of the Project
- Describe the design and materials of the biodegradable antibacterial scaffold.
- Evaluate how the scaffold supports new bone formation in a controlled setting.
- Assess the antibacterial effectiveness and safety in vitro (lab tests).
- Preliminarily test the scaffold’s behavior in a small animal or simulation model, if applicable.
- Identify practical considerations for clinical use, such as handling and integration with implants.
What You Will Do Step by Step
1) Review existing scaffolds and antibacterial agents chosen for the project.
2) Prepare or simulate scaffold samples and characterize their properties.
3) Conduct lab tests to see how well bone cells grow on the scaffold and how bacteria are affected.
4) Analyze data to compare bone growth with and without the scaffold.
5) Discuss safety, potential side effects, and clinical practicality.
6) Compile findings into a cohesive assessment with clear limitations.
Expected Outcome
Anticipated results include evidence that the scaffold supports bone growth while reducing infection risk, along with practical guidance for future clinical trials and potential improvements in materials or design.